These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 32425936)
1. MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides. Talsma DT; Poppelaars F; Dam W; Meter-Arkema AH; Vivès RR; Gál P; Boons GJ; Chopra P; Naggi A; Seelen MA; Berger SP; Daha MR; Stegeman CA; van den Born J; Front Immunol; 2020; 11():732. PubMed ID: 32425936 [TBL] [Abstract][Full Text] [Related]
2. Co-complexes of MASP-1 and MASP-2 associated with the soluble pattern-recognition molecules drive lectin pathway activation in a manner inhibitable by MAp44. Degn SE; Jensen L; Olszowski T; Jensenius JC; Thiel S J Immunol; 2013 Aug; 191(3):1334-45. PubMed ID: 23785123 [TBL] [Abstract][Full Text] [Related]
3. Role of MBL-associated serine protease (MASP) on activation of the lectin complement pathway. Takahashi M; Mori S; Shigeta S; Fujita T Adv Exp Med Biol; 2007; 598():93-104. PubMed ID: 17892207 [TBL] [Abstract][Full Text] [Related]
4. Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway. Takahashi M; Iwaki D; Kanno K; Ishida Y; Xiong J; Matsushita M; Endo Y; Miura S; Ishii N; Sugamura K; Fujita T J Immunol; 2008 May; 180(9):6132-8. PubMed ID: 18424734 [TBL] [Abstract][Full Text] [Related]
5. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway. Møller-Kristensen M; Thiel S; Sjöholm A; Matsushita M; Jensenius JC Int Immunol; 2007 Feb; 19(2):141-9. PubMed ID: 17182967 [TBL] [Abstract][Full Text] [Related]
6. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation. Kozarcanin H; Lood C; Munthe-Fog L; Sandholm K; Hamad OA; Bengtsson AA; Skjoedt MO; Huber-Lang M; Garred P; Ekdahl KN; Nilsson B J Thromb Haemost; 2016 Mar; 14(3):531-45. PubMed ID: 26614707 [TBL] [Abstract][Full Text] [Related]
7. A novel mannose-binding lectin/ficolin-associated protein is highly expressed in heart and skeletal muscle tissues and inhibits complement activation. Skjoedt MO; Hummelshoj T; Palarasah Y; Honore C; Koch C; Skjodt K; Garred P J Biol Chem; 2010 Mar; 285(11):8234-43. PubMed ID: 20053996 [TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of the lectin pathway of complement with phage display selected peptides against mannose-binding lectin-associated serine protease (MASP)-1 and -2: significant contribution of MASP-1 to lectin pathway activation. Kocsis A; Kékesi KA; Szász R; Végh BM; Balczer J; Dobó J; Závodszky P; Gál P; Pál G J Immunol; 2010 Oct; 185(7):4169-78. PubMed ID: 20817870 [TBL] [Abstract][Full Text] [Related]
9. Structural and functional overview of the lectin complement pathway: its molecular basis and physiological implication. Matsushita M; Endo Y; Fujita T Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):273-83. PubMed ID: 23563865 [TBL] [Abstract][Full Text] [Related]
10. Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2. Héja D; Kocsis A; Dobó J; Szilágyi K; Szász R; Závodszky P; Pál G; Gál P Proc Natl Acad Sci U S A; 2012 Jun; 109(26):10498-503. PubMed ID: 22691502 [TBL] [Abstract][Full Text] [Related]
11. Molecular interactions between MASP-2, C4, and C2 and their activation fragments leading to complement activation via the lectin pathway. Wallis R; Dodds AW; Mitchell DA; Sim RB; Reid KB; Schwaeble WJ J Biol Chem; 2007 Mar; 282(11):7844-51. PubMed ID: 17204478 [TBL] [Abstract][Full Text] [Related]
12. Quantitative characterization of the activation steps of mannan-binding lectin (MBL)-associated serine proteases (MASPs) points to the central role of MASP-1 in the initiation of the complement lectin pathway. Megyeri M; Harmat V; Major B; Végh Á; Balczer J; Héja D; Szilágyi K; Datz D; Pál G; Závodszky P; Gál P; Dobó J J Biol Chem; 2013 Mar; 288(13):8922-34. PubMed ID: 23386610 [TBL] [Abstract][Full Text] [Related]
13. Purification, measurement of concentration, and functional complement assay of human ficolins. Matsushita M; Kilpatrick D; Shiraki H; Liu Y; Tateishi K; Tsujimura M; Endo Y; Fujita T Methods Mol Biol; 2014; 1100():141-59. PubMed ID: 24218257 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the interaction between L-ficolin/p35 and mannan-binding lectin-associated serine proteases-1 and -2. Cseh S; Vera L; Matsushita M; Fujita T; Arlaud GJ; Thielens NM J Immunol; 2002 Nov; 169(10):5735-43. PubMed ID: 12421953 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus. Neth O; Jack DL; Johnson M; Klein NJ; Turner MW J Immunol; 2002 Oct; 169(8):4430-6. PubMed ID: 12370377 [TBL] [Abstract][Full Text] [Related]
16. Dissociation and re-association studies on the interaction domains of mannan-binding lectin (MBL)-associated serine proteases, MASP-1 and MASP-2, provide evidence for heterodimer formation. Paréj K; Hermann A; Donáth N; Závodszky P; Gál P; Dobó J Mol Immunol; 2014 May; 59(1):1-9. PubMed ID: 24424083 [TBL] [Abstract][Full Text] [Related]
17. Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. Selander B; Mårtensson U; Weintraub A; Holmström E; Matsushita M; Thiel S; Jensenius JC; Truedsson L; Sjöholm AG J Clin Invest; 2006 May; 116(5):1425-34. PubMed ID: 16670774 [TBL] [Abstract][Full Text] [Related]
18. Properdin Pattern Recognition on Proximal Tubular Cells Is Heparan Sulfate/Syndecan-1 but Not C3b Dependent and Can Be Blocked by Tick Protein Salp20. Lammerts RGM; Talsma DT; Dam WA; Daha MR; Seelen MAJ; Berger SP; van den Born J Front Immunol; 2020; 11():1643. PubMed ID: 32849563 [No Abstract] [Full Text] [Related]
19. The control of the complement lectin pathway activation revisited: both C1-inhibitor and antithrombin are likely physiological inhibitors, while α2-macroglobulin is not. Paréj K; Dobó J; Závodszky P; Gál P Mol Immunol; 2013 Jul; 54(3-4):415-22. PubMed ID: 23399388 [TBL] [Abstract][Full Text] [Related]
20. Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies. Loeven MA; Maciej-Hulme ML; Yanginlar C; Hubers MC; Kellenbach E; de Graaf M; van Kuppevelt TH; Wetzels J; Rabelink TJ; Smith RJH; van der Vlag J Front Immunol; 2021; 12():676662. PubMed ID: 34489931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]